{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:32:53Z","timestamp":1778841173603,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"FIST (DST, Govt. of India)"},{"name":"CAS (UGC, Govt. of India)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jmgm.2017.06.011","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T22:00:48Z","timestamp":1496959248000},"page":"294-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Inhibition activities of catechol diether based non-nucleoside inhibitors against the HIV reverse transcriptase variants: Insights from molecular docking and ONIOM calculations"],"prefix":"10.1016","volume":"75","author":[{"given":"Pabitra Narayan","family":"Samanta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalyan Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2017.06.011_bib0005","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1126\/science.1078050","article-title":"The early years of HIV\/AIDS","volume":"298","author":"Gallo","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2017.06.011_bib0010","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMp038194","article-title":"The discovery of HIV as the cause of AIDS","volume":"349","author":"Gallo","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0015","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1039\/c2cs35058k","article-title":"In search of a treatment For HIV \u2212current therapies and the role of non-nucleoside reverse transcriptase inhibitors (NNRTIs)","volume":"41","author":"Reynolds","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0020","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1021\/jm00014a001","article-title":"Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections","volume":"38","author":"De Clercq","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1098-1128(200003)20:2<129::AID-MED2>3.0.CO;2-A","article-title":"The HIV-1 reverse transcription (RT) process as target for RT inhibitors","volume":"20","author":"Jonckheere","year":"2000","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1128\/CMR.8.2.200","article-title":"Antiviral therapy for human immunodeficiency virus infections","volume":"8","author":"De Clercq","year":"1995","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0035","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1021\/bi00240a001","article-title":"HIV reverse transcriptase structure-function relationships","volume":"30","author":"Jacobo-Molina","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmgm.2017.06.011_bib0040","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1126\/science.1377403","article-title":"Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor","volume":"256","author":"Kohlstaedt","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2017.06.011_bib0045","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2174\/1381612024607162","article-title":"Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches","volume":"8","author":"Tarrago-Litvak","year":"2002","journal-title":"Curr. Pharm. Design"},{"key":"10.1016\/j.jmgm.2017.06.011_bib0050","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijantimicag.2008.10.010","article-title":"Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV","volume":"33","author":"De Clercq","year":"2009","journal-title":"Int. J. Antimicrob. Ag."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/rmv.624","article-title":"The history of antiretrovirals: key discoveries over the past 25 years","volume":"19","author":"De Clercq","year":"2009","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2009.09.008","article-title":"Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989\u20132009)","volume":"85","author":"de B\u00e9thune","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pharmtox-010510-100228","article-title":"A 40-year journey in search of selective antiviral chemotherapy","volume":"51","author":"De Clercq","year":"2011","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0070","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1021\/jm960056x","article-title":"Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors","volume":"39","author":"Hopkins","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0075","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1006\/jmbi.1998.2208","article-title":"Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody fab fragment at 2.8 \u00c5 resolution","volume":"284","author":"Ding","year":"1998","journal-title":"J. Mol. Bio."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0080","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1016\/S0960-894X(03)00681-4","article-title":"Activity predictions for efavirenz analogues with the K103N mutant of HIV reverse transcriptase","volume":"13","author":"Udier-Blagovi\u0107","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.coviro.2013.03.012","article-title":"HIV-1 reverse transcriptase and antiviral drug resistance. Part 1","volume":"3","author":"Das","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.coviro.2013.03.014","article-title":"HIV-1 reverse transcriptase and antiviral drug resistance. Part 2","volume":"3","author":"Das","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0095","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.bmcl.2006.02.024","article-title":"Tetrazole thioacetanilides: potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant","volume":"16","author":"Muraglia","year":"2006","journal-title":"Bioorg. Med. Chem. Letts."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1006\/jmbi.2001.4988","article-title":"Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors","volume":"312","author":"Ren","year":"2001","journal-title":"J. Mol. Bio."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0105","doi-asserted-by":"crossref","first-page":"10718","DOI":"10.1128\/JVI.79.16.10718-10729.2005","article-title":"High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations","volume":"79","author":"Ceccherini-Silberstein","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0110","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1021\/jm030558s","volume":"47","author":"Das","year":"2004","journal-title":"J. Med. Chem ."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0115","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1073\/pnas.0711209105","article-title":"High-resolution structures of HIV-1 reverse transcriptase\/TMC278 complexes: strategic flexibilityexplains potency against resistance mutations","volume":"105","author":"Das","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0120","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1021\/jm1002233","article-title":"crystal structures of HIV-1 reverse transcriptase with etravirine (TMC125) and rilpivirine (TMC278): implications for drug design","volume":"53","author":"Lansdon","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0125","doi-asserted-by":"crossref","first-page":"8582","DOI":"10.1021\/jm201134m","article-title":"Computationally-guided optimization of a docking hit to yield catechol diethers as potent anti-HIV agents","volume":"54","author":"Bollini","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0130","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1021\/ci200203h","article-title":"Combined approach using ligand efficiency, cross-docking, and antitarget hits for wild-type and drug-resistant Y181C HIV-1 reverse transcriptase","volume":"51","author":"Garc\u00eda-Sosa","year":"2011","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/j.jmgm.2017.06.011_bib0135","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00894-011-1190-5","article-title":"Docking-based 3D-QSAR analyses of pyrazole derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors","volume":"18","author":"Cichero","year":"2012","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0140","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s00894-011-1236-8","article-title":"Docking, molecular dynamics and quantitative structure- activity relationship studies for HEPTs and DABOs as HIV-1 reverse transcriptase inhibitors","volume":"18","author":"Mao","year":"2012","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0145","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1021\/ci400427a","article-title":"Assessing molecular docking tools for relative bological activityprediction: a case study of triazole HIV-1 NNRTIs","volume":"53","author":"Fr\u0105czek","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0150","doi-asserted-by":"crossref","first-page":"13754","DOI":"10.1039\/C4RA15397A","article-title":"Molecular modeling studies of dihydro-alkyloxy-benzyl-oxopyrimidines (DABOs) as non-nucleoside inhibitors of HIV-1 reverse transcriptase using 3D-QSAR, Topomer CoMFA and molecular docking simulations","volume":"5","author":"Dong","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-1280(98)00475-8","article-title":"A new ONIOM implementation in Gaussian98. Part I. The calculation of energies, gradients, vibrational frequencies and electric field derivatives","volume":"461-462","author":"Dapprich","year":"1999","journal-title":"J. Mol. Struc THEOCHEM"},{"key":"10.1016\/j.jmgm.2017.06.011_bib0160","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/ct050289g","article-title":"Combining quantum mechanics methods with molecular mechanics methods in ONIOM","volume":"2","author":"Vreven","year":"2006","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0165","first-page":"456","article-title":"Theoretical investigation on nevirapine and HIV-1 revers transcriptase binding site interaction, based on ONIOM method, Chem","volume":"380","author":"Kuno","year":"2003","journal-title":"Phys. Letts."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0170","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cplett.2005.02.023","article-title":"Particular interaction between efavirenz and the HIV-1 reverse transcriptase binding site as explained by the ONIOM2 method","volume":"405","author":"Nunrium","year":"2005","journal-title":"Chem. Phys. Letts."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0175","first-page":"859","article-title":"Binding energy analysis for wild-type and Y181C mutant HIV 1 RT\/8-Cl TIBO complex structures: quantum chemical calculations based on the ONIOM method, Proteins: structure, Function","volume":"61","author":"Saen-oon","year":"2005","journal-title":"and Bioinformatics"},{"key":"10.1016\/j.jmgm.2017.06.011_bib0180","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1039\/c1md00162k","article-title":"Key interactions of the mutant HIV-1 reverse transcriptase\/efavirenz: an evidence obtained from ONIOM method","volume":"2","author":"Boonsri","year":"2011","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0185","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ejmech.2012.03.032","article-title":"Synthesis, structure?activity relationships, and docking studies of N-phenylarylformamide derivatives (PAFAs) as non-nucleoside HIV reverse transcriptase inhibitors","volume":"58","author":"Ma","year":"2012","journal-title":"Euro. J. Med Chem."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0190","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1016\/j.bmc.2012.02.037","article-title":"Synthesis, biological activity and docking study of imidazol- 5-one as novel non-nucleoside HIV-1 reverse transcriptase inhibitors","volume":"20","author":"Mokale","year":"2012","journal-title":"Bioorg Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0195","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.bmc.2013.12.045","article-title":"Design and synthesis of N1-aryl-benzimidazoles 2-substituted as novel HIV-1 non- nucleoside reverse transcriptase inhibitors","volume":"22","author":"Monforte","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0200","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1021\/jm501908a","article-title":"Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variants","volume":"58","author":"Frey","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0205","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/cbdd.12266","article-title":"Structure-based evaluation of C5 derivatives in the catechol diether series targeting HIV-1 reverse transcriptase","volume":"83","author":"Frey","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0210","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDockTools4. AutoDock4 Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0215","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0220","series-title":"Proceedings of the ACS Meeting","article-title":"Molecular docking using ArgusLab, an efficient shape-based search algorithm and AScore scoring function","author":"Thompson","year":"2004"},{"key":"10.1016\/j.jmgm.2017.06.011_bib0225","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0230","series-title":"Gaussian 09 Revision A.01","author":"Frisch","year":"2009"},{"key":"10.1016\/j.jmgm.2017.06.011_bib0235","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1063\/1.464304","article-title":"A new mixing of Hartree?Fock and local density\u2010functional theories","volume":"98","author":"Becke","year":"1993","journal-title":"J. Chem. Phys"},{"key":"10.1016\/j.jmgm.2017.06.011_bib0240","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density-functional thermochemistry. iii. the role of exact exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0245","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","article-title":"Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density","volume":"37","author":"Lee","year":"1988","journal-title":"Phys. Rev. B"},{"key":"10.1016\/j.jmgm.2017.06.011_bib0250","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00894-007-0233-4","article-title":"Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elements","volume":"13","author":"Stewart","year":"2007","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0255","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1021\/ja100936w","article-title":"Revealing noncovalent interactions","volume":"132","author":"Johnson","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0260","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","article-title":"Multiwfn A multifunctional wavefunction analyzer","volume":"33","author":"Lu","year":"2012","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0265","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD. - visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graphics"},{"key":"10.1016\/j.jmgm.2017.06.011_bib0270","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.1039\/c3cp50466b","article-title":"Theoretical ECD calculations \u2212a useful tool for estimating the conformational change of a ligand in the binding pocket of proteins","volume":"15","author":"Ionescu","year":"2013","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0275","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejmech.2012.04.004","article-title":"Chiral resolution, absolute configuration assignment and biological activity of racemic diarylpyrimidine CH(OH)-DAPY as potent nonnucleoside HIV-1 reverse transcriptase inhibitors","volume":"53","author":"Gu","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0280","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1063\/1.436185","article-title":"Electronegativity: the density functional viewpoint","volume":"68","author":"Parr","year":"1978","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0285","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1021\/ja00905a001","article-title":"Hard and soft acids and bases","volume":"85","author":"Pearson","year":"1963","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0290","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1021\/ja00364a005","article-title":"Absolute hardness: companion parameter to absolute electronegativity","volume":"105","author":"Parr","year":"1983","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0295","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1021\/ja00005a073","article-title":"HSAB principle","volume":"113","author":"Chattaraj","year":"1991","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0300","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1021\/ja00082a031","article-title":"An ab initio study resulting in a greater understanding of the HSAB principle","volume":"116","author":"Chattaraj","year":"1994","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2017.06.011_bib0305","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1021\/ja983494x","article-title":"Electrophilicity index","volume":"121","author":"Parr","year":"1999","journal-title":"J. Am. Chem. Soc"}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326317300724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326317300724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:55:48Z","timestamp":1761080148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326317300724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":61,"alternative-id":["S1093326317300724"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2017.06.011","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition activities of catechol diether based non-nucleoside inhibitors against the HIV reverse transcriptase variants: Insights from molecular docking and ONIOM calculations","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2017.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}